-
Mark L. Baum, J.D.
Chief Executive Officer, Member, Board of Directors
Mark L. Baum is the founder and CEO of Imprimis Pharmaceuticals. He is also the founder and board member of Eton Pharmaceuticals, Surface Pharmaceuticals, and Melt Pharmaceuticals. Read More
-
Andrew R. Boll, CFA, CMA
Chief Financial Officer
Mr. Boll is one of our founding employees at Imprimis. As our Chief Financial Officer and Corporate Secretary, he oversees the Company’s financial and administrative operations including its accounting, financial reporting, investor relations, human resources, legal and other administrative departments. Read More
-
John Saharek
Chief Commercial Officer
Mr. Saharek started with Imprimis in 2013 and is our Chief Commercial Officer. Mr. Saharek oversees all of our commercial activities, including strategic planning, marketing, sales, business development, and market access. Read More
Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745
Interested in receiving investor news and updates?
Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.
